Banque Pictet & Cie Sa Has Decreased By $13.45 Million Its Teva Pharmaceutical Inds LTD (TEVA) Holding; Ashmore Group Plc Decreased Grupo Financiero Galicia S A (GGAL) Position

October 13, 2017 - By Marguerite Chambers

Banque Pictet & Cie Sa decreased Teva Pharmaceutical Inds Ltd (TEVA) stake by 86.25% reported in 2017Q2 SEC filing. Banque Pictet & Cie Sa sold 407,438 shares as Teva Pharmaceutical Inds Ltd (TEVA)’s stock declined 15.11%. The Banque Pictet & Cie Sa holds 64,945 shares with $2.15 million value, down from 472,383 last quarter. Teva Pharmaceutical Inds Ltd now has $15.92B valuation. The stock rose 0.07% or $0.01 reaching $14.99. About 27.18M shares traded or 11.30% up from the average. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since October 13, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Ashmore Group Plc decreased Grupo Financiero Galicia S A (GGAL) stake by 98.11% reported in 2017Q2 SEC filing. Ashmore Group Plc sold 137,952 shares as Grupo Financiero Galicia S A (GGAL)’s stock rose 23.69%. The Ashmore Group Plc holds 2,653 shares with $113,000 value, down from 140,605 last quarter. Grupo Financiero Galicia S A now has $6.38B valuation. The stock rose 0.09% or $0.05 reaching $54.71. About 271,360 shares traded. Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) has risen 63.44% since October 13, 2016 and is uptrending. It has outperformed by 46.74% the S&P500.

Banque Pictet & Cie Sa increased Netflix Inc (NASDAQ:NFLX) stake by 24,333 shares to 50,713 valued at $7.58 million in 2017Q2. It also upped Noble Energy Inc (NYSE:NBL) stake by 17,000 shares and now owns 49,000 shares. Bright Horizons Fam Sol In D (NYSE:BFAM) was raised too.

Analysts await Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) to report earnings on November, 21. They expect $1.05 earnings per share, down 17.97% or $0.23 from last year’s $1.28 per share. TEVA’s profit will be $1.12B for 3.57 P/E if the $1.05 EPS becomes a reality. After $0.99 actual earnings per share reported by Teva Pharmaceutical Industries Ltd (ADR) for the previous quarter, Wall Street now forecasts 6.06% EPS growth.

Among 29 analysts covering Teva Pharma (NYSE:TEVA), 8 have Buy rating, 4 Sell and 17 Hold. Therefore 28% are positive. Teva Pharma had 97 analyst reports since July 21, 2015 according to SRatingsIntel. Mizuho maintained the stock with “Neutral” rating in Wednesday, November 16 report. The company was upgraded on Friday, September 2 by Oppenheimer. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Underperform” rating by JMP Securities on Wednesday, September 6. The firm has “Buy” rating given on Friday, June 16 by Mizuho. The rating was maintained by Oppenheimer with “Hold” on Wednesday, October 4. The stock has “Buy” rating by Mizuho on Monday, December 7. The firm has “Hold” rating by Maxim Group given on Thursday, July 13. The firm has “Buy” rating given on Thursday, July 14 by Jefferies. The firm has “Neutral” rating by Credit Suisse given on Friday, August 4. The firm earned “Overweight” rating on Tuesday, May 3 by Morgan Stanley.

Among 3 analysts covering Grupo Financiero Galicia (NASDAQ:GGAL), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Grupo Financiero Galicia had 5 analyst reports since August 7, 2015 according to SRatingsIntel. As per Monday, August 22, the company rating was upgraded by Citigroup. Credit Suisse upgraded the shares of GGAL in report on Friday, October 28 to “Outperform” rating. The firm has “Neutral” rating given on Tuesday, February 9 by JP Morgan. The stock of Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) earned “Buy” rating by Zacks on Friday, August 7. The stock of Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) earned “Neutral” rating by Credit Suisse on Tuesday, March 29.

Analysts await Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) to report earnings on November, 8. GGAL’s profit will be $109.62M for 14.55 P/E if the $0.94 EPS becomes a reality. After $0.82 actual EPS reported by Grupo Financiero Galicia S.A. (ADR) for the previous quarter, Wall Street now forecasts 14.63% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com